LEUPROLIDE for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where LEUPROLIDE was used for Neoplasm.
Most Reported Side Effects for LEUPROLIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hot flush | 9,146 | 12.9% | 189 | 604 |
| Death | 8,772 | 12.4% | 8,757 | 739 |
| Intercepted product preparation error | 8,621 | 12.2% | 5 | 6 |
| Syringe issue | 7,847 | 11.1% | 9 | 12 |
| Device leakage | 5,861 | 8.3% | 7 | 8 |
| Wrong technique in product usage process | 5,062 | 7.1% | 6 | 14 |
| Fatigue | 4,805 | 6.8% | 223 | 631 |
| Injection site pain | 4,678 | 6.6% | 174 | 281 |
| Prostatic specific antigen increased | 2,432 | 3.4% | 225 | 297 |
| Asthenia | 2,176 | 3.1% | 216 | 578 |
| Off label use | 2,060 | 2.9% | 73 | 221 |
| Drug ineffective | 2,057 | 2.9% | 97 | 218 |
| Fall | 1,922 | 2.7% | 272 | 1,130 |
| Arthralgia | 1,756 | 2.5% | 66 | 225 |
| Prostate cancer | 1,736 | 2.5% | 836 | 306 |
Other Indications for LEUPROLIDE
Prostate cancer (45,399)
Product used for unknown indication (10,600)
Endometriosis (4,494)
Precocious puberty (2,032)
Uterine leiomyoma (1,547)
Prostate cancer metastatic (1,109)
Bulbospinal muscular atrophy congenital (678)
Breast cancer (609)
Hormone-refractory prostate cancer (262)
Gender dysphoria (223)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)